Real-world safety and effectiveness analysis of low-dose preschool sesame oral immunotherapy

Real-world safety and effectiveness analysis of low-dose preschool sesame oral immunotherapy

Background: Previous studies support the effectiveness of sesame oral immunotherapy (S-OIT) in patients >4 years old using maintenance doses of 1200 mg protein. However, tahini is often not palatable to children, and high-maintenance doses may not be possible for preschoolers. Objective: We studi...

Full description

Bibliographic Details
Main Authors: Gilbert T. Chua, MBBS, Lianne Soller, PhD, Sandeep Kapur, MD, Mary McHenry, MD, Gregory A. Rex, MD, Victoria E. Cook, MSc, MD, Scott B. Cameron, MD, PhD, Edmond S. Chan, MD, Joanne Yeung, MD, Stephanie C. Erdle, MD
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Sesame
oral immunotherapy
low dose
preschoolers
allergy
Online Access:http://www.sciencedirect.com/science/article/pii/S2772829323000966

Internet

http://www.sciencedirect.com/science/article/pii/S2772829323000966

Similar Items